Physician

Celina C Bernabe, DO

According to 2025 Medicare claims, Celina Bernabe, DO (NPI: 1063518546) practices allergy/immunology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is ALLERGY AND ASTHMA CARE, P.A. (NPI: 1821194390; TIN: 48-0971495) and primary practice location at 66211-1371.

Bernabe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 409 traditional Medicare patients, billed 17,612 HCPCS/CPT codes, and received $672,351 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,451 prescription claims across 368 beneficiaries totaling $3,209,720 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 569 claims. Open Payments data shows 166 records totaling $13,099. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $43,433 to $672,351. Similarly, Part D prescription costs have risen steadily, from $40,262 to $3,209,720. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $6,815 to $17,759.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	165	2,563	$43,433
2016	198	3,364	$65,112
2017	198	5,677	$106,756
2018	249	5,087	$125,697
2019	238	9,071	$260,456
2020	205	7,897	$226,968
2021	255	9,902	$300,363
2022	366	12,880	$539,463
2023	415	13,751	$714,051
2024	409	17,612	$672,351

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	96	322	$40,262
2016	132	472	$48,379
2017	137	518	$715,206
2018	250	723	$150,130
2019	310	1,127	$319,853
2020	342	1,162	$529,049
2021	386	1,289	$1,004,732
2022	472	1,631	$1,504,689
2023	381	1,354	$2,502,268
2024	368	1,451	$3,209,720

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	267	$353,176
2016	N/R	318	$389,026
2017	22	408	$410,731
2018	22	344	$326,335
2019	11	372	$354,301
2020	38	558	$659,446
2021	43	568	$714,536
2022	30	551	$764,832
2023	28	545	$781,625
2024	23	569	$908,238

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	57	76	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	269	677	$80
95165	Professional service for preparation and provision of 1 or more antigens	131	1,188	$9
95117	Professional service for multiple injections of allergen	96	464	$7
89190	Nasal smear for eosinophils (allergy related white blood cells)	91	120	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	80	2,240	$612,865
Ayvakit	Avapritinib	12	360	$465,623
Icatibant	Icatibant Acetate	19	542	$185,623
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	26	728	$76,150
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	2,130	$44,467

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	12	130	$563,553
J1557	Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	11	$94,938
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	27	$80,352
J1551	Injection, immune globulin (cutaquig), 100 mg	N	N/R	17	$76,937
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	14	$42,909

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	166	$13,099	Pharming Healthcare, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Celina C. Bernabe, DO?

Tedicare shows public-source Medicare data for Celina C. Bernabe, DO (NPI 1063518546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Celina C. Bernabe, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Celina C. Bernabe, DO?

Celina C. Bernabe, DO is linked to ALLERGY AND ASTHMA CARE, P.A. (billing NPI 1821194390) in the available physician profile data.

Does Celina C. Bernabe, DO have Open Payments data?

Celina C. Bernabe, DO has 166 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.